CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system
Samia J. Khoury(Brigham and Women's Hospital), Wayne W. Hancock(Children's Hospital of Philadelphia), Mohamed H. Sayegh(Brigham and Women's Hospital), Peter S. Linsley(Bristol-Myers Squibb (Germany)), Enver Akalin(Brigham and Women's Hospital), Laurence A. Turka(University of Pennsylvania), Anil Chandraker(Brigham and Women's Hospital)
Cited by 202
Related Papers
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
CTLA-4 is a second receptor for the B cell activation antigen B7.
|The Journal of Experimental Medicine|1991|1.7k
Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 4
|The Journal of Immunology|2001|953
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
|RNA|2006|785
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|708